Related references
Note: Only part of the references are listed.Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL)
Kell A. Cycon et al.
EXPERIMENTAL HEMATOLOGY (2009)
CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression
Lisa M. Rimsza et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV
Sarah T. Wilkinson et al.
LEUKEMIA & LYMPHOMA (2009)
HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma
Arjan Diepstra et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival
Robin A. Roberts et al.
BLOOD (2006)
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions
LM Rimsza et al.
BLOOD (2006)
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
LM Rimsza et al.
BLOOD (2004)
Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system
ES Jordanova et al.
GENES CHROMOSOMES & CANCER (2002)
Share Paper
